Clinical Trial Update: PRAGUE-25 Trial. Catheter Ablation vs. AADs and Risk Factor Modification. [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing catheter ablation to antiarrhythmic drugs with risk factor modification for atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Charles University, Czech Republic | Conditions: Atrial Fibrillation | Phase 3 | Status: UNKNOWN